nodes	percent_of_prediction	percent_of_DWPC	metapath
Salmeterol—Labetalol—CYP2D6—schizophrenia	0.00704	0.303	CrCbGaD
Salmeterol—Propafenone—CYP1A2—schizophrenia	0.00697	0.3	CrCbGaD
Salmeterol—Propafenone—CYP2D6—schizophrenia	0.00538	0.232	CrCbGaD
Salmeterol—Propafenone—ABCB1—schizophrenia	0.00384	0.165	CrCbGaD
Salmeterol—ADRB2—Signaling Pathways—DGKI—schizophrenia	0.000797	0.000816	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CHRM1—schizophrenia	0.000795	0.000814	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—PRKD1—schizophrenia	0.000791	0.00081	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—NDUFV2—schizophrenia	0.00079	0.000808	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—IL3RA—schizophrenia	0.000775	0.000793	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PLCH2—schizophrenia	0.000753	0.000771	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—CCK—schizophrenia	0.000744	0.000762	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PIP4K2A—schizophrenia	0.000742	0.00076	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—GRM5—schizophrenia	0.000739	0.000757	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PPP1R1B—schizophrenia	0.000729	0.000746	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—PDE4B—schizophrenia	0.000726	0.000743	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—CCKAR—schizophrenia	0.000714	0.000731	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—CYP2D6—schizophrenia	0.000712	0.000729	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—NDST3—schizophrenia	0.000708	0.000725	CbGpPWpGaD
Salmeterol—CYP3A4—Metapathway biotransformation—CYP2D6—schizophrenia	0.000703	0.000719	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—MPC2—schizophrenia	0.000702	0.000718	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—ADORA2A—schizophrenia	0.000692	0.000709	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—FZD3—schizophrenia	0.000678	0.000694	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CCK—schizophrenia	0.000676	0.000692	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—CYP26B1—schizophrenia	0.000671	0.000687	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—SLC27A5—schizophrenia	0.000671	0.000687	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ACSL6—schizophrenia	0.000671	0.000687	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—PDE4B—schizophrenia	0.000659	0.000675	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—CLOCK—schizophrenia	0.000654	0.00067	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PLCH2—schizophrenia	0.000652	0.000668	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CCKAR—schizophrenia	0.000648	0.000664	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—NPY—schizophrenia	0.000647	0.000662	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—CYP1A2—schizophrenia	0.000644	0.00066	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—DAO—schizophrenia	0.00064	0.000656	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—TAAR6—schizophrenia	0.000637	0.000652	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—FES—schizophrenia	0.000637	0.000652	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PPP3CC—schizophrenia	0.000637	0.000652	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—GRM2—schizophrenia	0.000637	0.000652	CbGpPWpGaD
Salmeterol—CYP3A4—Metapathway biotransformation—CYP1A2—schizophrenia	0.000635	0.000651	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—HTR2A—schizophrenia	0.00063	0.000645	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—ADORA2A—schizophrenia	0.000629	0.000643	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—OXT—schizophrenia	0.000624	0.000639	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—HTR1B—schizophrenia	0.000624	0.000639	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PNP—schizophrenia	0.000614	0.000629	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—NDST3—schizophrenia	0.000613	0.000628	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—HTR1A—schizophrenia	0.000601	0.000615	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—TPH1—schizophrenia	0.000598	0.000613	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—GCLM—schizophrenia	0.000598	0.000613	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—NPS—schizophrenia	0.000591	0.000606	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—NGEF—schizophrenia	0.00059	0.000604	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—NPY—schizophrenia	0.000587	0.000601	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—SLC27A5—schizophrenia	0.000581	0.000595	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ACSL6—schizophrenia	0.000581	0.000595	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—DRD1—schizophrenia	0.00058	0.000594	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—HTR2C—schizophrenia	0.00058	0.000594	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—NTS—schizophrenia	0.000576	0.00059	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—NDUFV2—schizophrenia	0.000571	0.000584	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3C2A—schizophrenia	0.000568	0.000582	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—HTR1B—schizophrenia	0.000567	0.00058	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—OXT—schizophrenia	0.000567	0.00058	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PRKD1—schizophrenia	0.000563	0.000576	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—DRD3—schizophrenia	0.000562	0.000575	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—DAO—schizophrenia	0.000555	0.000568	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—HTR1A—schizophrenia	0.000545	0.000558	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—DRD4—schizophrenia	0.000545	0.000558	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—GRM3—schizophrenia	0.000542	0.000555	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—RGS4—schizophrenia	0.000542	0.000555	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—RTN4—schizophrenia	0.000542	0.000555	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—COMT—schizophrenia	0.00054	0.000553	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—GSTP1—schizophrenia	0.000537	0.00055	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—NPS—schizophrenia	0.000537	0.00055	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PIP4K2A—schizophrenia	0.000537	0.000549	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—MAOA—schizophrenia	0.000536	0.000549	CbGpPWpGaD
Salmeterol—CYP3A4—Metapathway biotransformation—COMT—schizophrenia	0.000532	0.000545	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PNP—schizophrenia	0.000532	0.000544	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—HTR6—schizophrenia	0.000532	0.000544	CbGpPWpGaD
Salmeterol—CYP3A4—Metapathway biotransformation—GSTP1—schizophrenia	0.00053	0.000543	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—HTR2C—schizophrenia	0.000527	0.000539	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—DRD1—schizophrenia	0.000527	0.000539	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—CNR1—schizophrenia	0.000521	0.000533	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—MAG—schizophrenia	0.000514	0.000526	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—DRD3—schizophrenia	0.00051	0.000522	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—HTR7—schizophrenia	0.000508	0.00052	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—DRD2—schizophrenia	0.000508	0.00052	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—DRD4—schizophrenia	0.000495	0.000507	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—NDUFV2—schizophrenia	0.000494	0.000506	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—GSTM1—schizophrenia	0.000494	0.000506	CbGpPWpGaD
Salmeterol—CYP3A4—Metapathway biotransformation—GSTM1—schizophrenia	0.000487	0.000499	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CYP26B1—schizophrenia	0.000485	0.000497	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CNR1—schizophrenia	0.000473	0.000484	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CHRM1—schizophrenia	0.00047	0.000481	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—GAPDH—schizophrenia	0.00047	0.000481	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—CLOCK—schizophrenia	0.000465	0.000476	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PIP4K2A—schizophrenia	0.000465	0.000476	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PRODH—schizophrenia	0.000462	0.000473	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—HTR7—schizophrenia	0.000461	0.000472	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—DRD2—schizophrenia	0.000461	0.000472	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—schizophrenia	0.000461	0.000472	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—IL3RA—schizophrenia	0.000458	0.000469	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—TPH2—schizophrenia	0.000453	0.000464	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—CACNB2—schizophrenia	0.000453	0.000464	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—TLE1—schizophrenia	0.000447	0.000457	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—NRG3—schizophrenia	0.000447	0.000457	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—DPYD—schizophrenia	0.000446	0.000457	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—GFAP—schizophrenia	0.000442	0.000452	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—GRM5—schizophrenia	0.000437	0.000447	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—TPH1—schizophrenia	0.000433	0.000443	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GCLM—schizophrenia	0.000433	0.000443	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—TLE3—schizophrenia	0.000423	0.000433	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CYP26B1—schizophrenia	0.00042	0.00043	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—CACNA1C—schizophrenia	0.000415	0.000425	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PRKD1—schizophrenia	0.000407	0.000416	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PIK3C2A—schizophrenia	0.000404	0.000414	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CCK—schizophrenia	0.000399	0.000409	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PDE4B—schizophrenia	0.000389	0.000398	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CCKAR—schizophrenia	0.000383	0.000392	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—MPC2—schizophrenia	0.000377	0.000386	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—TPH1—schizophrenia	0.000375	0.000384	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GCLM—schizophrenia	0.000375	0.000384	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—ADORA2A—schizophrenia	0.000371	0.00038	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—PLA2G4A—schizophrenia	0.000365	0.000374	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—CYP2D6—schizophrenia	0.000363	0.000371	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—SNAP25—schizophrenia	0.000363	0.000371	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—FGA—schizophrenia	0.000356	0.000364	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—HTR2A—schizophrenia	0.000356	0.000364	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	0.000353	0.000362	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PRKD1—schizophrenia	0.000352	0.000361	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PLCH2—schizophrenia	0.00035	0.000358	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—NPY—schizophrenia	0.000347	0.000355	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—NOTCH4—schizophrenia	0.000347	0.000355	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—ATP2A2—schizophrenia	0.000347	0.000355	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GAPDH—schizophrenia	0.000339	0.000347	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CLOCK—schizophrenia	0.000336	0.000344	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—HTR1B—schizophrenia	0.000335	0.000343	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—OXT—schizophrenia	0.000335	0.000343	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—NDST3—schizophrenia	0.000329	0.000337	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—CYP1A2—schizophrenia	0.000328	0.000336	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—TPH2—schizophrenia	0.000328	0.000336	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CACNB2—schizophrenia	0.000328	0.000336	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—TH—schizophrenia	0.000323	0.000331	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—HTR2A—schizophrenia	0.000323	0.000331	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—DPYD—schizophrenia	0.000322	0.00033	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—HTR1A—schizophrenia	0.000322	0.00033	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—NPS—schizophrenia	0.000317	0.000325	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—SLC27A5—schizophrenia	0.000312	0.000319	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ACSL6—schizophrenia	0.000312	0.000319	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—HTR2C—schizophrenia	0.000311	0.000319	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—DRD1—schizophrenia	0.000311	0.000319	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—NTRK2—schizophrenia	0.000303	0.00031	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—DRD3—schizophrenia	0.000301	0.000309	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CACNA1C—schizophrenia	0.0003	0.000307	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—DAO—schizophrenia	0.000298	0.000305	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GAPDH—schizophrenia	0.000294	0.000301	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—DRD4—schizophrenia	0.000293	0.000299	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PIK3C2A—schizophrenia	0.000292	0.000299	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CLOCK—schizophrenia	0.000291	0.000298	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—APOE—schizophrenia	0.000291	0.000298	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	0.000287	0.000294	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PNP—schizophrenia	0.000285	0.000292	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—TPH2—schizophrenia	0.000284	0.000291	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CACNB2—schizophrenia	0.000284	0.000291	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—DPYD—schizophrenia	0.000279	0.000286	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CNR1—schizophrenia	0.000279	0.000286	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—COMT—schizophrenia	0.000275	0.000281	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—GSTP1—schizophrenia	0.000273	0.00028	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—MAOA—schizophrenia	0.000273	0.000279	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—DRD2—schizophrenia	0.000273	0.000279	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—HTR7—schizophrenia	0.000273	0.000279	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—NDUFV2—schizophrenia	0.000265	0.000272	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—SNAP25—schizophrenia	0.000262	0.000268	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CYP2D6—schizophrenia	0.000262	0.000268	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CACNA1C—schizophrenia	0.00026	0.000266	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ABCB1—schizophrenia	0.000259	0.000265	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PRL—schizophrenia	0.000257	0.000263	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PIK3C2A—schizophrenia	0.000253	0.000259	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—GSTM1—schizophrenia	0.000251	0.000257	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PLA2G4A—schizophrenia	0.000251	0.000257	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PIP4K2A—schizophrenia	0.000249	0.000255	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—S100B—schizophrenia	0.00024	0.000246	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CYP1A2—schizophrenia	0.000237	0.000243	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—TH—schizophrenia	0.000234	0.000239	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—ERBB4—schizophrenia	0.000229	0.000235	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—SNAP25—schizophrenia	0.000227	0.000232	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CYP2D6—schizophrenia	0.000227	0.000232	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CYP26B1—schizophrenia	0.000226	0.000231	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—MTHFR—schizophrenia	0.000222	0.000227	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PLA2G4A—schizophrenia	0.000216	0.000221	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—NRG1—schizophrenia	0.000212	0.000217	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—MEF2C—schizophrenia	0.00021	0.000215	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—APOE—schizophrenia	0.000207	0.000212	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CYP1A2—schizophrenia	0.000205	0.00021	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—APOA1—schizophrenia	0.000204	0.000209	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—YWHAZ—schizophrenia	0.000203	0.000208	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—TH—schizophrenia	0.000202	0.000207	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GCLM—schizophrenia	0.000201	0.000206	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—TPH1—schizophrenia	0.000201	0.000206	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—COMT—schizophrenia	0.000199	0.000203	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—ERBB3—schizophrenia	0.000198	0.000203	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GSTP1—schizophrenia	0.000198	0.000202	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—MAOA—schizophrenia	0.000197	0.000202	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—HTR2A—schizophrenia	0.000191	0.000195	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PRKD1—schizophrenia	0.000189	0.000194	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ABCB1—schizophrenia	0.000187	0.000192	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PLA2G4A—schizophrenia	0.000182	0.000186	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GSTM1—schizophrenia	0.000182	0.000186	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—APOE—schizophrenia	0.000177	0.000182	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—APOA1—schizophrenia	0.000175	0.00018	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—COMT—schizophrenia	0.000172	0.000176	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GSTP1—schizophrenia	0.000171	0.000175	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—MAOA—schizophrenia	0.000171	0.000175	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—ESR1—schizophrenia	0.000169	0.000173	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—EP300—schizophrenia	0.000166	0.00017	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ABCB1—schizophrenia	0.000162	0.000166	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—MTHFR—schizophrenia	0.000161	0.000164	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GAPDH—schizophrenia	0.000158	0.000162	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PLA2G4A—schizophrenia	0.000157	0.000161	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GSTM1—schizophrenia	0.000157	0.000161	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CLOCK—schizophrenia	0.000156	0.00016	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—GSK3B—schizophrenia	0.000154	0.000157	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—TPH2—schizophrenia	0.000152	0.000156	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CACNB2—schizophrenia	0.000152	0.000156	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—DPYD—schizophrenia	0.00015	0.000153	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—APOE—schizophrenia	0.000149	0.000153	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—APOA1—schizophrenia	0.000148	0.000151	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CACNA1C—schizophrenia	0.000139	0.000143	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—MTHFR—schizophrenia	0.000139	0.000142	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PIK3C2A—schizophrenia	0.000136	0.000139	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—APOE—schizophrenia	0.000129	0.000133	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—APOA1—schizophrenia	0.000128	0.000131	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—SNAP25—schizophrenia	0.000122	0.000125	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CYP2D6—schizophrenia	0.000122	0.000125	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—EP300—schizophrenia	0.000118	0.000121	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—AKT1—schizophrenia	0.000114	0.000117	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CYP1A2—schizophrenia	0.00011	0.000113	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—TH—schizophrenia	0.000109	0.000111	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—AKT1—schizophrenia	0.000103	0.000106	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—EP300—schizophrenia	0.000101	0.000104	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—COMT—schizophrenia	9.23e-05	9.45e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GSTP1—schizophrenia	9.19e-05	9.41e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—MAOA—schizophrenia	9.17e-05	9.39e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ABCB1—schizophrenia	8.7e-05	8.91e-05	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—EP300—schizophrenia	8.52e-05	8.72e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PLA2G4A—schizophrenia	8.44e-05	8.65e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GSTM1—schizophrenia	8.44e-05	8.65e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—MTHFR—schizophrenia	7.46e-05	7.64e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—EP300—schizophrenia	7.38e-05	7.55e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—TP53—schizophrenia	7.24e-05	7.41e-05	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—AKT1—schizophrenia	7.12e-05	7.29e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—APOE—schizophrenia	6.95e-05	7.11e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—APOA1—schizophrenia	6.87e-05	7.03e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—AKT1—schizophrenia	6.11e-05	6.26e-05	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—AKT1—schizophrenia	5.15e-05	5.27e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—AKT1—schizophrenia	4.46e-05	4.56e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—EP300—schizophrenia	3.96e-05	4.05e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—AKT1—schizophrenia	2.39e-05	2.45e-05	CbGpPWpGaD
